Back
Regeneron Pharmaceuticals Stock Predictions
Buy
65
REGN
Regeneron Pharmaceuticals
Last Price:
982.60
Seasonality Move:
8.1%
7 Day Trial
ALL ACCESS PASS
$
7
Regeneron Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 32% based on the past 33 years of stock performance.
- Regeneron Pharmaceuticals has risen higher in 18 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Regeneron Pharmaceuticals Stock Undervalued?
The current Regeneron Pharmaceuticals [REGN] share price is $982.29. The Score for REGN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal. - REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 32% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Buy
65
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals overpriced?
- Regeneron Pharmaceuticals has risen higher in 18 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
998.33
52-Week Low:
684.81
Prediction Charts
Market Cap:
108.23B
Price in USD:
982.29
Volume:
386.46K
Beta:
0.95
Technical Analysis
SMA50:
942.80
SMA100:
941.55
SMA200:
880.68
52-Wk Change:
31.04%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?
Yes, Regeneron Pharmaceuticals is a publicly traded company. -
What is the Regeneron Pharmaceuticals stock quote today?
The Regeneron Pharmaceuticals stock price is 982.29 USD today. -
How to buy Regeneron Pharmaceuticals stock online?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 892.11 | 890.59 | 896.85 | 885.01 |
May-1 | 889.41 | 903.02 | 913.21 | 888.52 |
May-2 | 900.00 | 937.61 | 943.77 | 891.30 |
May-3 | 926.94 | 957.00 | 958.13 | 926.94 |
May-6 | 958.00 | 958.64 | 962.10 | 950.27 |
May-7 | 967.88 | 969.97 | 970.56 | 957.10 |
May-8 | 969.90 | 955.76 | 971.86 | 952.14 |
May-9 | 959.59 | 968.00 | 969.98 | 956.76 |
May-10 | 970.00 | 973.80 | 979.98 | 966.85 |
May-13 | 980.00 | 976.96 | 982.58 | 970.99 |
May-14 | 980.00 | 984.64 | 987.80 | 970.95 |
May-15 | 988.00 | 978.21 | 988.96 | 966.34 |
May-16 | 978.27 | 967.98 | 978.30 | 967.41 |
May-17 | 969.27 | 982.29 | 982.77 | 966.00 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.59 per share, and an increase next year of $3.24 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.